Skip to main content

NEFERTITI: A Novel Eco-Friendly, dually Efficient and Resistance-free Treatment of vaginITIs

Project description

A tablet for vaginal infections

The female genital tract is colonised by bacterial species such as lactobacilli which offer protection against various infections. However, bacterial or yeast infections are common and cause significant discomfort. Treatment involves the oral or topical administration of antibiotics or antifungals, but due to drug resistance, these regimens are not always successful, and infections recur. The EU-funded NEFERTITI project has developed a vaginal tablet for treating yeast and bacterial infections while keeping the vaginal microbiota intact. The tablet contains a natural substance that restores the normal pH in the vagina which is elevated during an infection. Treatment removes pathogenic microorganisms and reduces the risk of recurrent infections.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Coordinator

GEDEA BIOTECH AB
Net EU contribution
€ 50 000,00
Address
Medicon Village Scheelevagen 2
223 81 Lund
Sweden

See on map

Region
Södra Sverige Sydsverige Skåne län
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 21 429,00